Remdesivir is a drug that shows promise with COVID 19. A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macques monkeys with Covid-19.
Remdesivir development code GS-5734 is an antiviral medication developed by the American biophar
But recently I have read conflicting reports. The Gilead company has again changed their phase 3 protocol. First the initial news was that 2,400 patients would be recruited. Good. I was happy to hear that Now today I read that 6000 will be recruited. Why the sudden change. This brings up doubt that maybe the initial data might be disappointing. Maybe the patients are not benefiting from the drug
Remdesivir is an investigational drug not used to treat any disease currently. The company Gilead has changed the way we treat HIV positive patients. Let’s hope something can be used to change the face of COVID 19.